公司资料
Adicet Bio 股价、新闻与催化剂
- 股票代码:
- ACET
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
8.74 USD (+4.30%)
收盘价
最后更新: 2026年8月17日
75.8M USD
市值
股价为何变动
As of Aug 17, 2026, ACET closed up 4.30% at $8.74. No new same-company headline was identified in the current news window.
公司概览
业务概览
Adicet Bio is a cell-therapy company focused on gamma delta T-cell therapies for cancer and immune disease. Its platform is trying to create off-the-shelf cell therapies with broader utility.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Adicet sits in advanced cell therapy.
商业模式特征
The business depends on platform validation, manufacturing execution, and early clinical proof-of-concept.
生物医药行业定位
Adicet is a high-catalyst cell-therapy name whose valuation is highly sensitive to translational progress.
未来催化剂
- Adicet’s catalysts are ADI-001 and the rest of its allogeneic gamma delta CAR-T platform. The company needs clinical updates that keep the allogeneic story credible.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。